No. 20-6545
Michael Meadows v. United States
Response WaivedIFP
Tags: criminal-procedure cumulative-error-doctrine drug-enforcement drug-profile-testimony due-process evidence expert-testimony judicial-procedure legal-admissibility trial-evidence trial-practice
Key Terms:
DueProcess CriminalProcedure Privacy
DueProcess CriminalProcedure Privacy
Latest Conference:
2021-01-15
Question Presented (AI Summary)
Does drug profile testimony have any legitimate use as trial evidence?
Question Presented (OCR Extract)
QUESTIONS PRESENTED I. Does drug profile testimony have any legitimate use as trial evidence? I. Does the cumulative error doctrine exist and, if so, can errors to which no objections are made be accumulated when they demonstrate a denial of due process? ii
Docket Entries
2021-01-19
Petition DENIED.
2020-12-30
DISTRIBUTED for Conference of 1/15/2021.
2020-12-18
Waiver of right of respondent United States to respond filed.
2020-10-26
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due January 6, 2021)
Attorneys
Michael Meadows
Gregory C. Sasse — Gregory C. Sasse LLC, Petitioner
Gregory C. Sasse — Gregory C. Sasse LLC, Petitioner
United States
Jeffrey B. Wall — Acting Solicitor General, Respondent
Jeffrey B. Wall — Acting Solicitor General, Respondent